[VRDN] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
12-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 14.62%
YoY- 51.08%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 1,090 1,451 54 0 168 828 880 15.35%
PBT -17,964 -18,460 -90,742 -5,494 -6,435 -8,044 -10,118 46.67%
Tax 9 55 130 -48 33 27 50 -68.15%
NP -17,964 -18,460 -90,742 -5,494 -6,435 -8,044 -10,118 46.67%
Tax Rate - - - - - - - -
Total Cost 19,054 19,911 90,796 5,494 6,603 8,872 10,998 44.29%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -1,648.07 -1,272.23 -168,040.74 0.00 -3,830.36 -971.50 -1,149.77 27.15%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -2.22 -2.91 -23.07 -1.48 -1.82 -2.65 -4.69 -39.29%
EPS Diluted -2.22 -2.91 -23.07 -1.48 -1.82 -2.65 -4.69 -39.29%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.